Clinical Study Details

Chronic Obstructive Pulmonary Disease (COPD) is a lung condition that makes it hard to breathe. It can also be called chronic bronchitis or emphysema.

Symptoms include shortness of breath, wheezing, chest tightness, and coughing. COPD gets worse over time and whilst there is no cure, treatments can help manage symptoms and improve quality of life.

Studies have shown that using a combination of inhaled medications may be more effective in reducing exacerbations, or flare-ups and improving lung function compared to using just one type of medicine.

Here at AusTrials, we are conducting a study that will explore the efficacy of an investigational combination of medications to prevent serious heart and lung issues in people with COPD.

To be eligible to participate in this study, we are looking for people who:

• Are between 40-80 years old.
• Have been diagnosed with COPD, chronic bronchitis or emphysema.
• Are a current or former smoker AND,
• Have established cardiovascular disease (e.g., history of heart attacks, blocked
  arteries, heart failure, heart bypass) OR are at risk for a first cardiovascular event (e.g.,
  suffer from high blood pressure, diabetes, high cholesterol)

Please note: Participants who have used inhaled steroids within the last 12-months or have an active diagnosis of asthma will be ineligible.

Study treatments and procedures will be provided free of charge and participants will be reimbursed for reasonable expenses associated with study visits.

Study duration: The study has an approximate duration of 3 years and involves 11 visits (both virtual and clinic visits).

This study is being conducted at the following locations:

AusTrials Taringa – Brisbane, QLD
AusTrials Sunshine – Melbourne, VIC

Please contact AusTrials on 1300 190 841 for further information or follow the link below.